What do patients really want when facing oesophageal cancer surgery?
NCT ID NCT07828314
First seen Sep 18, 2026 ยท Last updated Sep 18, 2026
Summary
Researchers want to understand what patients with early oesophageal cancer value most when deciding whether to have major surgery. The study uses interviews and a choice experiment with about 118 people under care for Barrett's, dysplasia, or oesophageal cancer. Participants answer questions about their priorities and how they interpret the risks doctors explain during the consent process.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- interviews and a discrete choice experiment about treatment priorities
- What this could lead to
- If successful, this could help doctors tailor treatment decisions to what patients with early oesophageal cancer value most.
- What could go wrong
- This is a small qualitative study, so its findings may not apply to all patients or treatment settings. It does not test a new treatment and cannot show whether any approach works better.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
118 people
The number who actually took part.
- Started
-
Aug 2025
- Finished
-
Aug 2026
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients who are undergoing surveillance or endoscopic treatment for Barret's oesophagus, dysplasia, or oesophageal cancer.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Under care of local MDT for monitoring/surveillance/treatment of Barretts/dysplasia/oesophageal cancer * able to communicate in English Language Exclusion Criteria: * Unable or unwilling to give informed consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Barrett esophagus are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Portsmouth Hospitals University NHS Trust
Portsmouth, Hampshire, PO6 3LY, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Swallowable capsule and lab test take on endoscopy for esophageal cancer screening
- Can a Pre-Surgery checklist predict who will still have reflux after fundoplication?
- New acid blocker may offer stronger reflux control for Barrett's esophagus
- Can we spot cancer before it starts? a massive study aims to find out
- Pulsing radiation may spare esophageal cancer patients from agonizing throat pain
- Electric pulses and diet: a new weapon against muscle loss in stomach and bowel cancers?